---
figid: PMC5768892__gr6
figlink: /pmc/articles/PMC5768892/figure/fig6/
number: F6
caption: 'GCN5 Affects Multiple Components of the FGF Signaling Pathway and Activates
  Selective Targets during Early DifferentiationTop: the abnormal phenotype of Gcn5−/−
  EBs becomes evident early during EB differentiation (day 5). Loss of Gcn5 leads
  to disorganization of the epiblast architecture that is associated with defective
  cytoskeleton networks (F-actin and vimentin) and decreases in progenitors fated
  for mesoderm. At later stages of differentiation (days 9 and 12), Gcn5−/− EBs are
  smaller in size and express lower levels of marker genes for ectoderm (blue), endoderm
  (green), and mesoderm (magenta), compared with the controls. Lighter shades indicate
  decreased expression levels of marker genes for each population. Middle: at day
  5, GCN5 affects expression of multiple genes encoding critical components in FGF
  signaling and for proper activation of ERK and p38 pathways. Solid diamond, up (red)
  or down (green) regulated transcripts; open diamond (green), decreased protein expression;
  double open diamond (green), decreased protein phosphorylation. Bottom: at day 5,
  GCN5 is required for activation of genes important for signaling through promoter-associated
  H3K9ac, including four cMYC targets (blue).'
pmcid: PMC5768892
papertitle: GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes
  during Early Embryoid Body Differentiation.
reftext: Li Wang, et al. Stem Cell Reports. 2018 Jan 9;10(1):287-299.
pmc_ranked_result_index: '103988'
pathway_score: 0.475401
filename: gr6.jpg
figtitle: Gcn5−/− EBs becomes evident early during EB differentiation
year: '2018'
organisms: Homo sapiens
ndex: 89c884d8-de93-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5768892__gr6.html
  '@type': Dataset
  description: 'GCN5 Affects Multiple Components of the FGF Signaling Pathway and
    Activates Selective Targets during Early DifferentiationTop: the abnormal phenotype
    of Gcn5−/− EBs becomes evident early during EB differentiation (day 5). Loss of
    Gcn5 leads to disorganization of the epiblast architecture that is associated
    with defective cytoskeleton networks (F-actin and vimentin) and decreases in progenitors
    fated for mesoderm. At later stages of differentiation (days 9 and 12), Gcn5−/−
    EBs are smaller in size and express lower levels of marker genes for ectoderm
    (blue), endoderm (green), and mesoderm (magenta), compared with the controls.
    Lighter shades indicate decreased expression levels of marker genes for each population.
    Middle: at day 5, GCN5 affects expression of multiple genes encoding critical
    components in FGF signaling and for proper activation of ERK and p38 pathways.
    Solid diamond, up (red) or down (green) regulated transcripts; open diamond (green),
    decreased protein expression; double open diamond (green), decreased protein phosphorylation.
    Bottom: at day 5, GCN5 is required for activation of genes important for signaling
    through promoter-associated H3K9ac, including four cMYC targets (blue).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCE
  - BCAT1
  - MAPK1
  - GRB10
  - PIK3CB
  - MAPK3
  - GLDC
  - PRKCD
  - MAPK14
  - PRKCG
  - PRKCB
  - PRKCH
  - PRKCI
  - PRKCQ
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - NRAS
  - PIK3CD
  - PIK3R3
  - PRKD3
  - PRKCA
  - NMNAT2
  - MAPK11
  - AKT3
  - AKT1
  - AKT2
  - PIK3R6
  - PRKCZ
  - HRAS
  - KRAS
  - IGF1R
  - INSR
  - MTHFD2
  - MYC
  - STAT3
  - MAPK13
  - MAPK12
  - PIK3CG
  - RPS6KA2
  - SPRY4
  - SRM
  - Cancer
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Bcat1
  symbol: BCAT1
  source: hgnc_symbol
  hgnc_symbol: BCAT1
  entrez: '586'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GRB10-
  symbol: GRB10
  source: hgnc_symbol
  hgnc_symbol: GRB10
  entrez: '2887'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Gldc
  symbol: GLDC
  source: hgnc_symbol
  hgnc_symbol: GLDC
  entrez: '2731'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Nmnat2
  symbol: NMNAT2
  source: hgnc_symbol
  hgnc_symbol: NMNAT2
  entrez: '23057'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: INSR/IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: INSR/IGFR
  symbol: INSR
  source: hgnc_symbol
  hgnc_symbol: INSR
  entrez: '3643'
- word: Mthfd2
  symbol: MTHFD2
  source: hgnc_symbol
  hgnc_symbol: MTHFD2
  entrez: '10797'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Rps6ka2
  symbol: RPS6KA2
  source: hgnc_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: SPRY4
  symbol: SPRY4
  source: hgnc_symbol
  hgnc_symbol: SPRY4
  entrez: '81848'
- word: Srm
  symbol: SRM
  source: hgnc_symbol
  hgnc_symbol: SRM
  entrez: '6723'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5768892__F6
redirect_from: /figures/PMC5768892__F6
figtype: Figure
---
